In addition, DNAJB9 is involved in the degradation of cystic fibrosis-associated proteins as a tubulointerstitial co-chaperone and is a therapeutic target in cystic fibrosis nephritis [50]. This evidence concerns the gene DNAJB9 and cystic fibrosis.